R0N
Roniciclib
| Created: | 2016-02-25 |
| Last modified: | 2022-10-18 |
Find Related PDB Entry |
|---|
Find related ligands: |
|---|
Chemical Details | |
|---|---|
| Formal Charge | 0 |
| Atom Count | 50 |
| Chiral Atom Count | 3 |
| Bond Count | 52 |
| Aromatic Bond Count | 12 |
Chemical Component Summary | |
|---|---|
| Name | Roniciclib |
| Synonyms | BAY 1000394 |
| Systematic Name (OpenEye OEToolkits) | (2~{R},3~{R})-3-[2-[[4-(cyclopropylsulfonimidoyl)phenyl]amino]-5-(trifluoromethyl)pyrimidin-4-yl]oxybutan-2-ol |
| Formula | C18 H21 F3 N4 O3 S |
| Molecular Weight | 430.445 |
| Type | NON-POLYMER |
Chemical Descriptors | |||
|---|---|---|---|
| Type | Program | Version | Descriptor |
| SMILES | ACDLabs | 12.01 | c3(c(nc(Nc2ccc(S(C1CC1)(N)O)cc2)nc3)OC(C(O)C)C)C(F)(F)F |
| SMILES | CACTVS | 3.385 | C[CH](O)[CH](C)Oc1nc(Nc2ccc(cc2)[S](=N)(=O)C3CC3)ncc1C(F)(F)F |
| SMILES | OpenEye OEToolkits | 3.1.0.0 | CC(C(C)Oc1c(cnc(n1)Nc2ccc(cc2)S(=N)(=O)C3CC3)C(F)(F)F)O |
| Canonical SMILES | CACTVS | 3.385 | C[C@@H](O)[C@@H](C)Oc1nc(Nc2ccc(cc2)[S@](=N)(=O)C3CC3)ncc1C(F)(F)F |
| Canonical SMILES | OpenEye OEToolkits | 3.1.0.0 | C[C@H]([C@@H](C)Oc1c(cnc(n1)Nc2ccc(cc2)S(=N)(=O)C3CC3)C(F)(F)F)O |
| InChI | InChI | 1.06 | InChI=1S/C18H21F3N4O3S/c1-10(26)11(2)28-16-15(18(19,20)21)9-23-17(25-16)24-12-3-5-13(6-4-12)29(22,27)14-7-8-14/h3-6,9-11,14,22,26H,7-8H2,1-2H3,(H,23,24,25)/t10-,11-,29+/m1/s1 |
| InChIKey | InChI | 1.06 | UELYDGOOJPRWGF-SRQXXRKNSA-N |
Drug Info: DrugBank
DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
| DrugBank ID | DB12974 |
|---|---|
| Name | Roniciclib |
| Groups | investigational |
| Description | Roniciclib has been investigated for the treatment of Small Cell Lung Carcinoma. |
| Synonyms | Roniciclib |
| Categories | Sulfur Compounds |
| CAS number | 1223498-69-8 |
Drug Targets
DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
| Name | Target Sequence | Pharmacological Action | Actions |
|---|---|---|---|
| Cyclin-dependent kinase 2 | MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR... | unknown | inhibitor |
| Cyclin-dependent kinase 9 | MAKQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV... | unknown | inhibitor |
| Cyclin-dependent kinase 4 | MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLP... | unknown | inhibitor |
| Cyclin-dependent kinase 1 | MEDYTKIEKIGEGTYGVVYKGRHKTTGQVVAMKKIRLESEEEGVPSTAIR... | unknown | inhibitor |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
| Resource Name | Reference |
|---|---|
| Pharos | CHEMBL4282338 |
| PubChem | 71494949 |
| ChEMBL | CHEMBL4282338 |
